Active cytomegalovirus retinitis after the start of antiretroviral therapy

Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first enter...

Full description

Bibliographic Details
Main Authors: Heiden, D, Tun, N, Smithuis, F, Keenan, J, Oldenburg, C, Holland, G, Drew, W
Format: Journal article
Published: BMJ Publishing Group 2018
_version_ 1797102250979491840
author Heiden, D
Tun, N
Smithuis, F
Keenan, J
Oldenburg, C
Holland, G
Drew, W
author_facet Heiden, D
Tun, N
Smithuis, F
Keenan, J
Oldenburg, C
Holland, G
Drew, W
author_sort Heiden, D
collection OXFORD
description Patients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART.
first_indexed 2024-03-07T06:03:17Z
format Journal article
id oxford-uuid:ecf3c3fd-610f-4af6-83e7-9b6f6cfd5d52
institution University of Oxford
last_indexed 2024-03-07T06:03:17Z
publishDate 2018
publisher BMJ Publishing Group
record_format dspace
spelling oxford-uuid:ecf3c3fd-610f-4af6-83e7-9b6f6cfd5d522022-03-27T11:21:25ZActive cytomegalovirus retinitis after the start of antiretroviral therapyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ecf3c3fd-610f-4af6-83e7-9b6f6cfd5d52Symplectic Elements at OxfordBMJ Publishing Group2018Heiden, DTun, NSmithuis, FKeenan, JOldenburg, CHolland, GDrew, WPatients with AIDS-related cytomegalovirus (CMV) retinitis receiving combined antiretroviral therapy (cART), but not specific anti-CMV therapy, consistently showed active retinitis for several months. Delayed diagnosis and treatment of CMV retinitis may have severe consequences. Patients first entering care with advanced HIV infection and vulnerability to reactivation of latent CMV infection should be screened immediately for CMV retinitis by dilated indirect ophthalmoscopy and treated with specific anti-CMV therapy without delay, in addition to cART.
spellingShingle Heiden, D
Tun, N
Smithuis, F
Keenan, J
Oldenburg, C
Holland, G
Drew, W
Active cytomegalovirus retinitis after the start of antiretroviral therapy
title Active cytomegalovirus retinitis after the start of antiretroviral therapy
title_full Active cytomegalovirus retinitis after the start of antiretroviral therapy
title_fullStr Active cytomegalovirus retinitis after the start of antiretroviral therapy
title_full_unstemmed Active cytomegalovirus retinitis after the start of antiretroviral therapy
title_short Active cytomegalovirus retinitis after the start of antiretroviral therapy
title_sort active cytomegalovirus retinitis after the start of antiretroviral therapy
work_keys_str_mv AT heidend activecytomegalovirusretinitisafterthestartofantiretroviraltherapy
AT tunn activecytomegalovirusretinitisafterthestartofantiretroviraltherapy
AT smithuisf activecytomegalovirusretinitisafterthestartofantiretroviraltherapy
AT keenanj activecytomegalovirusretinitisafterthestartofantiretroviraltherapy
AT oldenburgc activecytomegalovirusretinitisafterthestartofantiretroviraltherapy
AT hollandg activecytomegalovirusretinitisafterthestartofantiretroviraltherapy
AT dreww activecytomegalovirusretinitisafterthestartofantiretroviraltherapy